Skip to content

Centria T4 Ria

by Clinical Diagnostics, Inc.

510(k) K761272

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK761272 Date16 Mar 1977ClearedStatusActive

Official records

From the FDA record

Received by the FDA
20 Dec 1976
FDA decision
16 Mar 1977 (Substantially Equivalent)
FDA review time
86 days from receipt to decision

From the FDA 510(k) record K761272 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
CDX
Device class
Class II
Regulation
21 CFR Part 862.1700
Advisory committee
Clinical Chemistry
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Centria T4 Ria is a radioimmunoassay device designed for the measurement of total thyroxine. It functions as a clinical chemistry diagnostic tool to assist in the assessment of thyroid function.

This device is regulated under FDA 510(k) number K761272 and is classified as a class 2 medical device. It is intended for use in clinical laboratory settings for the quantitative determination of total thyroxine in human serum.

Similar devices

Other devices filed under FDA product code CDX (Radioimmunoassay, Total Thyroxine).

Other devices from Clinical Diagnostics, Inc.

See all devices from Clinical Diagnostics, Inc. →